Primary Aldosteronism
Also known as: Primary hyperaldosteronism / Conn's syndrome / Idiopathic aldosteronism (disorder) / Conn Syndrome / Primary hyperaldosteronism (disorder)
Drug | Drug Name | Drug Description |
---|---|---|
DB12221 | Canrenone | An antimineralocorticoid and active metabolite of spironolactone used in the treatment of primary hyperaldosteronism and edematous states caused by secondary hyperaldosteronism (e.g. heart failure). |
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB00381 | Amlodipine | 2 | Completed | 1 |
DB01590 | Everolimus | 2 | Completed | 1 |
DB00700 | Eplerenone | 4 | Recruiting | 1 |
DB16165 | Finerenone | 4 | Not Yet Recruiting | 2 |
DB16165 | Finerenone | 4 | Recruiting | 2 |
DB01115 | Nifedipine | 4 | Recruiting | 1 |
DB00421 | Spironolactone | 4 | Not Yet Recruiting | 2 |
DB01284 | Tetracosactide | 4 | Unknown Status | 1 |
DB00594 | Amiloride | Not Available | Completed | 1 |
DB01197 | Captopril | Not Available | Unknown Status | 1 |
DB00568 | Cinnarizine | Not Available | Active Not Recruiting | 1 |
DB01285 | Corticotropin | Not Available | Completed | 1 |
DB01234 | Dexamethasone | Not Available | Completed | 1 |
DB00700 | Eplerenone | Not Available | Completed | 2 |
DB15207 | Esaxerenone | Not Available | Completed | 1 |
DB01115 | Nifedipine | Not Available | Active Not Recruiting | 1 |
DB00421 | Spironolactone | Not Available | Completed | 2 |
DB00421 | Spironolactone | Not Available | Recruiting | 2 |